Emerging roles of microRNAs in cancer.
暂无分享,去创建一个
[1] K. Somasundaram,et al. Impact of somatic copy number alterations on the glioblastoma miRNome: miR‐4484 is a genomically deleted tumour suppressor , 2017, Molecular oncology.
[2] M. Oren,et al. let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery , 2017, Oncogene.
[3] Z. Fang,et al. Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas , 2017, BMC Cancer.
[4] Mohammad Aslam Khan,et al. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK , 2017, British Journal of Cancer.
[5] D. Amadori,et al. Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers , 2016, Clinical Cancer Research.
[6] M. Iorio,et al. miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer. , 2016, Cancer research.
[7] Jia Yu,et al. DNA Methylation mediated down-regulating of MicroRNA-33b and its role in gastric cancer , 2016, Scientific Reports.
[8] Carlo M. Croce,et al. miR-15b/16-2 deletion promotes B-cell malignancies , 2015, Proceedings of the National Academy of Sciences.
[9] D. Amadori,et al. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. , 2015, Journal of the National Cancer Institute.
[10] G. Muto,et al. A microRNA code for prostate cancer metastasis , 2015, Oncogene.
[11] J. Meldolesi,et al. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. , 2015, Trends in cell biology.
[12] K. Ohyashiki,et al. Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. , 2014, Blood.
[13] U. Bhadra,et al. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells. , 2014, Gene.
[14] George A Calin,et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. , 2014, Cancer cell.
[15] Yul Ri Chung,et al. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer , 2014, Breast Cancer Research and Treatment.
[16] Y. Jeon,et al. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization , 2013, BMC Cancer.
[17] Graça Raposo,et al. Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.
[18] M. Rubin,et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. , 2012, The American journal of pathology.
[19] Roberta Galli,et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response , 2012, Proceedings of the National Academy of Sciences.
[20] Gema Moreno-Bueno,et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.
[21] P. Workman,et al. Discovery of small molecule cancer drugs: Successes, challenges and opportunities , 2012, Molecular oncology.
[22] F. Su,et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.
[23] E. Kroh,et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.
[24] K. Vickers,et al. MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.
[25] Jessica A. Weber,et al. Export of microRNAs and microRNA-protective protein by mammalian cells , 2010, Nucleic acids research.
[26] Frank Speleman,et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis , 2010, Nature Cell Biology.
[27] G. Gibbons,et al. The evolution of plasma cholesterol: direct utility or a "spandrel" of hepatic lipid metabolism? , 2009, Progress in lipid research.
[28] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[29] Yariv Yogev,et al. Serum MicroRNAs Are Promising Novel Biomarkers , 2008, PloS one.
[30] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[31] G. Cheon,et al. Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[32] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[33] C. Croce,et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[34] T. Whiteside,et al. Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles , 2006, Immunologic research.